Potential antibody therapy restricts the growth of aggressive and treatment-resistant breast cancersPotential antibody therapy restricts the growth of aggressive and treatment-resistant breast cancers
A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists.
GLP-1s and Heart Attacks, Strokes; Measles Outbreak Spreads; Using AI to Find PCPsGLP-1s and Heart Attacks, Strokes; Measles Outbreak Spreads; Using AI to Find PCPs
(MedPage Today) — Note that some links may require registration or subscription. Semaglutide (Wegovy) cut the risk for major heart events in people with obesity and cardiovascular disease regardless of how much weight they lost. (The Lancet… (MedPage Today) — Note that some links may require registration or subscription. Semaglutide (Wegovy) cut the risk Read More
Researchers seek to halt breast cancer recurrence by targeting “sleeper cells”Researchers seek to halt breast cancer recurrence by targeting “sleeper cells”
The results of a clinical trial published last month targeted breast cancer “sleeper cells,” which are cells that break away from the main tumor and can resurface later to spread cancer throughout the body.
Scientists seek to wipe out breast cancer’s “sleeper cells”Scientists seek to wipe out breast cancer’s “sleeper cells”
The results of a clinical trial published last month targeted breast cancer “sleeper cells,” which are cells that break away from the main tumor and can resurface later to spread cancer throughout the body. Elaine Quijano reports.
Wegovy has heart health benefits even if weight loss is minimalWegovy has heart health benefits even if weight loss is minimal
Studies have suggested that Wegovy directly boosts heart health, beyond just the benefits of losing weight, and now that has been demonstrated in a robust trial in people Studies have suggested that Wegovy directly boosts heart health, beyond just the benefits of losing weight, and now that has been demonstrated in a robust trial in Read More
Semaglutide helps heart regardless of how much weight lost, study revealsSemaglutide helps heart regardless of how much weight lost, study reveals
Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much weight people lose while taking the drug, according to a new study led by a UCL researcher. Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much weight people Read More
Study identifies factors affecting survival of patients with metastatic breast cancerStudy identifies factors affecting survival of patients with metastatic breast cancer
Researchers have identified factors associated with survival for patients initially diagnosed with metastatic breast cancer who were seen at UT Southwestern Medical Center and its affiliated sites. Their findings, published in Communications Medicine, list certain demographic and clinical characteristics to consider among the regional population when formulating treatment plans for individual patients.
Breast cancer survivors find relief for debilitating menopause symptomBreast cancer survivors find relief for debilitating menopause symptom
About 50% of menopausal women experience genitourinary syndrome of menopause (GSM) that involves changes to the genitals, including the vagina, urethra and bladder. When estrogen levels drop during menopause, it can cause the GSM symptoms of vaginal dryness, itching, burning, frequent urinary tract infections and pain during sex. Replenishing the hormone through vaginal estrogen is an effective GSM treatment. But many breast cancer survivors either can’t or don’t want to use estrogen.
AI mammogram readings are already helping doctors detect breast cancerAI mammogram readings are already helping doctors detect breast cancer
When reading women’s routine mammograms, radiologists are increasingly augmenting what they’re observing with artificial intelligence to better interpret the scan.
Scientists develop one-product-fits-all immunotherapy for breast cancerScientists develop one-product-fits-all immunotherapy for breast cancer
Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main targets that make other types of breast cancers more treatable with powerful therapies.